97 related articles for article (PubMed ID: 11735145)
1. Oncofetal fibronectin and oral squamous cell carcinoma.
Lyons AJ; Bateman AC; Spedding A; Primrose JN; Mandel U
Br J Oral Maxillofac Surg; 2001 Dec; 39(6):471-7. PubMed ID: 11735145
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
3. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
4. Salivary oncofoetal fibronectin and oral squamous cell carcinoma.
Lyons AJ; Cui N
J Oral Pathol Med; 2000 Jul; 29(6):267-70. PubMed ID: 10890557
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical metastasis.
Wallwork BD; Anderson SR; Coman WB
ANZ J Surg; 2007 Sep; 77(9):761-4. PubMed ID: 17685954
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of heat shock protein 27 is associated with good prognosis in the patient with oral squamous cell carcinoma.
Suzuki H; Sugimura H; Hashimoto K
Br J Oral Maxillofac Surg; 2007 Mar; 45(2):123-9. PubMed ID: 16720063
[TBL] [Abstract][Full Text] [Related]
12. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma.
Mese H; Sasaki A; Nakayama S; Yoshioka N; Yoshihama Y; Kishimoto K; Matsumura T
Oncol Rep; 2002; 9(2):341-4. PubMed ID: 11836604
[TBL] [Abstract][Full Text] [Related]
14. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
[TBL] [Abstract][Full Text] [Related]
15. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining with cytokeratin combining semi-serial sections for detection of cervical lymph node metastases of oral squamous cell carcinoma.
Guo CB; Li YA; Gao Y
Auris Nasus Larynx; 2007 Sep; 34(3):347-51. PubMed ID: 17399927
[TBL] [Abstract][Full Text] [Related]
19. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]